A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles
02 engineering and technology
0210 nano-technology
3. Good health
DOI:
10.1039/c4tb01533a
Publication Date:
2014-10-22T11:07:38Z
AUTHORS (8)
ABSTRACT
In this paper, an intracellular glutathione (GSH) responsive mesoporous silica nanoparticle (MSN-S-S-RGD) was developed as a drug nanocarrier by immobilizing the gatekeeper (RGD containing peptide) onto MSNs using disulfide bonds. The antitumor drug, DOX loaded porous structure of and DOX@MSN-S-S-RGD system has been proved to be effective nanocarrier. It determined that most could entrapped with only slight leakage. After being accumulated in tumor cells via receptor-mediated endocytosis, surface peptide layer removed trigger release kill cell due cleavage bonds GSH.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (29)
CITATIONS (133)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....